In this MD Newsline exclusive interview with Krystal Preston, PharmD, we discuss her pearls for treating patients with sickle cell disease. We also discuss how to address pharmacist implicit bias.

MD Newsline:

Is there anything else you would like to speak on that we have not already covered?

Krystal Preston, PharmD:

“I just want to emphasize that we as providers need to practice more active listening, empathy, and eliminating our pre-conceived biases when it comes to these patients. Most of the time, patients with sickle cell disease know how to best treat their pain because of the many times they have experienced pain crises. Just because they know what works for them does not mean they are drug-seeking.

Also, pain level is highly subjective, which is where our active listening and empathy will be most valued. Lastly, we should educate ourselves first and then educate the patient properly and encourage them to play a more active role in the collective decision-making process when it comes to their treatment.”

 

MD Newsline:

How can pharmacists address implicit bias in their work? How might their doing so improve healthcare for underserved communities?

Krystal Preston, PharmD:

“Pharmacists have a key role in addressing implicit bias and helping to improve healthcare in underserved areas because, often in these underserved areas, pharmacists are the first person to offer care in the community setting. In the hospital and clinic setting, pharmacists play a vital role in treatment evaluation and patient education on these treatments.

You May Also Like::  Sickle Cell Disease Complications and COVID-19

Overall, pharmacists are the unsung heroes who advocate for patients regarding treatment decision-making, patient counseling and education, and mitigating issues regarding costs and delivery of treatment.”

 

Responses have been condensed and lightly edited.

Categories